ACCELERATING EMERGING BIOPHARMASUCCESS
Ash�eld
ASHFIELD, THE PARTNER OF CHOICE FOR EMERGING BIOPHARMA
Emerging biopharma companies are driving the majority of the industry’s development pipeline and have a huge role to play in bringing innovative new medicines to market. However, the size of these companies is often a hurdle to getting treatments to patients and achieving business objectives efficiently.
Ashfield has the insights and experience to design tailored, integrated solutions. Our infrastructure allows us to execute efficiently and our flexibility means we plan and adapt very quickly to market response and volume trends.
“ The reason we partnered with Ashfield is because we’re small and we’re not trying to augment a sales force. We don’t have the infrastructure to start with such as incentive compensation, finances, cars, logistics, all that. We need them because they have this infrastructure built and that helps us tremendously. One of the best things about the relationship is the transparency…” VP of Sales
Specialists in go-to-market resources, all supported by state-of-the-art contact centers
• Expertise in specialty and rare disease
• Flexibility to grow and scale while mitigating risk, with a global footprint
• Unparalleled operational structure and systems to optimize performance, from recruitment, training and development, analytics and insights, to quality and compliance.
ASHFIELD COMMERCIALWe design and execute intelligent customer engagement models for emerging biopharma. Our unique approach involves:
ADAPTIVE ANALYTICSWith our agile data and analytics platform, every decision is driven by insight and designed to maximize ROI.
OPTIMIZED CHANNEL ENGAGEMENTIntelligent design to blend a range of resources and communication channels that effectively target and engage customers.
TAILORED EXECUTIONBuilding phenomenal teams and accelerating performance through genuine partnership and a culture of excellence.
Over 20 years’ experience
17 state-of-the-artcontact centers
21 country locations
Our global speciality experience includes:
AutoimmuneOncologyHepatitis C
HIVMultiple SclerosisNeurology
OUR COMMERCIAL SERVICESFOR EMERGING BIOPHARMA
COMMERCIAL JOURNEY
SCIENTIFIC ENGAGEMENT
MARKET ACCESS
ANALYTICS & INSIGHTS
ENGAGEMENT MODEL DESIGN TALENT LEARNING &
DEVELOPMENTEXECUTION &
ANALYTICS MEETINGS &
EVENTS
MSLs
Virtual MSLs
These services are delivered by our firewalled Medical Affairs business unit.
Research
Distribution and access strategy
Account team management
Forecasting and market sizing
Segmentation and targeting
Channel and frequency optimization
Field sales
Inside sales
Hybrid F2F/virtual reps
Specialty care teams
Key account managers
Commercial service reps
Pharmacy reps
Omnichannel engagement
Real-time recruitment
Vacancy management
Permanent recruitment
Onboarding
Trainingprograms
Measuring and responding to KPIs
Messaging effectiveness
ROI
Product launches and roadshows
Sales conferences and exhibitions
Virtual meetings
ASHFIELD PATIENT SOLUTIONS
Next-generation patient engagement programs for emerging biopharma, built on behavioral science, patient-centric technology and unparalleled collaboration. Our extensive experience:
ü ORPHANü ONCOLOGYü SPECIALTYü CHRONIC DISEASE
850>100
>30
97%
99%
ClinicalEducators
Programslaunched
Therapeuticareas
Self-management confidence
Overall satisfaction
2 100
Launch 13
Scalability
Strong client retention
Number of Clinical Educators per program
Programs from launch to 13 years
Our Patient Solutions Services for Emerging Biopharma
• Patient engagement programs, including health behaviour change and adherence strategies
• Patient education and training• Healthcare professional
education
Field based Clinical Educators
Contact Centers
Omnichannel 24/7 Support
OMNICHANNEL COMMUNICATIONS THROUGH ASHFIELD’S AWARD-WINNING PATIENT EXPERIENCE PLATFORM
Text/SMS communications
Connected devices / wearables
Video conferencing
Email/Mail
E-signature/survey
Printed materials and welcome kits
Social media and third party communities
HUB and specialty pharma
support
Mobile
Hospital to home support
In-home education
Phone and live chat
MEDICAL AFFAIRSWe are a nimble and flexible organization, offering dedicated, shared and hybrid staffing models. This allows emerging biopharma companies to manage operational costs and flex quickly in response to volume trends.
Our approach combines:
• Adverse event intake / reporting • Product complaint handling • Medical and technical information request handling
(Tier 1 and 2) • Medical writing• Crisis management • Compassionate use support• Conference support• Clinical trial support• REMS and patient registration support
Our Medical Information services
375+Medical
Informationstaff
Multichannel solutions to drive
customer experience and engagement
>97%Overall
quality score
UNSURPASSED EXPERTISELong-standing programs upheld by industry experts and cutting-edge technologies.
LEADING QUALITY STANDARDSRaising the bar for quality benchmarks, recruiting talented professionals and training for excellence.
GLOBAL AGILITYEfficient, global operations delivered through proactive, highly flexible partnerships.
To find out more about how Ashfield develops tailored, flexible solutions for emerging biopharma companies, please contact: [email protected]
MSLs, VIRTUAL MSLs AND MSL MANAGEMENT
Virtual MSL• Operate >80% remotely• Increase reach and frequency of
scientific exchange• Increase MSL team efficiency and
national coverage• Cost efficiency versus field MSLs
Current MSLs hold a doctorate degree (MD, PharmD, PhD)
>90%
REAL-TIME RECRUITMENT: Our executive search recruiters follow proven process and an agreed upon profile to build an essential candidate pool.
STRATEGIC INSIGHTS: We use our performance management process to ensure MSLs gather insights that drive medical strategy and high-quality education.
TECHNOLOGY: Our MSL model is underpinned by a full feature, compliant CRM and reporting platform.